Citation Impact
Citing Papers
Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model
2009
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Early interventions in severe sepsis and septic shock: a review of the evidence one decade later.
2012
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Protective Role of Hypoxia-Inducible Factor-2α against Ischemic Damage and Oxidative Stress in the Kidney
2007
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
The Role of Hypoxia in Vascular Injury and Repair
2008
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
2011
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Renal Sarcoidosis
2009
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Acidic pH inhibits ATP depletion-induced tubular cell apoptosis by blocking caspase-9 activation in apoptosome
2005
Acute kidney injury
2012 Standout
Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia
2005
Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity
2005
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Preconditional Activation of Hypoxia-Inducible Factors Ameliorates Ischemic Acute Renal Failure
2006
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy
2011
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
2009
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Experimental ischemia–reperfusion: biases and myths—the proximal vs. distal hypoxic tubular injury debate revisited
2009
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Use of a hanging-weight system for isolated renal artery occlusion during ischemic preconditioning in mice
2006
Long-term sequelae of acute kidney injury in the ICU
2012
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Erythropoiesis Stimulatory Agent- Resistant Anemia in Dialysis Patients: Review of Causes and Management
2009
Mitochondria-targeted antioxidant SkQR1 ameliorates gentamycin-induced renal failure and hearing loss
2012
Chronic kidney disease
2011 Standout
Sarcoidosis
2013 Standout
The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment
2011
Bridging Translation by Improving Preclinical Study Design in AKI
2015
Acute kidney injury
2019 Standout
Kidney-Heart Interactions
2005
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
2006
Natural history of vascular calcification in dialysis and transplant patients
2004
Cardiorenal Syndrome
2008 Standout
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Resolution of inflammation: the beginning programs the end
2005 Standout
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review
2007
Erythropoietin: ready for prime-time cardioprotection
2008
Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo
2005
Myocardial Reperfusion Injury
2007 Standout
Pathogenesis of vascular calcification in chronic kidney disease
2005
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Artificial Intelligence in Cardiology
2018 Standout
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol
2011
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease
2011
Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2
2013 StandoutNobel
Acute renal failure
2005
Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!
2010
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Apoptosis in glomerulonephritis
2005
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
2014 Standout
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
Amelioration of Renal Ischemia-Reperfusion Injury With a Novel Protective Cocktail
2011
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
2012
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Heart–kidney crosstalk and role of humoral signaling in critical illness
2014
A Randomized Trial of Protocol-Based Care for Early Septic Shock
2014 Standout
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Coronary Artery Calcification, Common Carotid Artery Intima-Media Thickness and Aortic Pulse Wave Velocity in Patients on Peritoneal Dialysis
2006
Vascular Calcification
2006 Standout
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
2012 StandoutNobel
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of Edward Sharples being referenced
Acute kidney injury: stimulation of repair
2007
Bench to bedside: A role for erythropoietin in sepsis
2010
Erythropoietin in Experimental Acute Renal Failure
2006
Erythropoietin Protects the Kidney against the Injury and Dysfunction Caused by Ischemia-Reperfusion
2004
Sarcoid tubulo-interstitial nephritis: Long-term outcome and response to corticosteroid therapy
2006
Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo
2004
Erythropoietin and Acute Renal Failure
2006
Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients
2004
Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients
2004
Novel applications of recombinant erythropoietin
2006
Mechanisms of Disease: cell death in acute renal failure and emerging evidence for a protective role of erythropoietin
2005
Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat
2006
ERYTHROPOIETIN ATTENUATES THE TISSUE INJURY ASSOCIATED WITH HEMORRHAGIC SHOCK AND MYOCARDIAL ISCHEMIA
2004
The Effect of Proinflammatory Cytokine Gene and Angiotensin-Converting Enzyme Polymorphisms on Erythropoietin Requirements in Patients on Continuous Ambulatory Peritoneal Dialysis
2006